NCT06246461 2024-02-07
The Therapeutic Effect of Different Doses of Capecitabine
Jingjiang People's Hospital
Phase NA Completed
Clinical Trials
10 trialsNCT02528175 2023-12-07
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT01295086 2020-11-02
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
Odense University Hospital
Phase NA Completed
NCT01828554 2019-11-25
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight
University of Wisconsin, Madison
Phase NA Completed
NCT02324452 2018-05-11
Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines
The Netherlands Cancer Institute
Phase NA Completed
NCT00763516 2017-09-06
PC02
University of Florida
Phase NA Completed
NCT00685763 2017-08-24
PC01
University of Florida
Phase NA Completed
NCT00146588 2015-03-24
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed
NCT00953537 2015-02-10
Predicting Response to Capecitabine in Women With Metastatic Breast Cancer
Centre Antoine Lacassagne
Phase NA Completed
NCT00121134 2013-12-24
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed